DEXCOM INC. DL-,001/ US2521311074 /
2024-05-23 8:38:32 PM | Chg. -3.900 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
116.680EUR | -3.23% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 46.18 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.